Assessment of the Platelet Adenosine Diphosphate Receptor (ADP Receptor p2y12) Polymorphism in Coronary Heart Diseases Patients in Ismailia
Mohamed, A., Abdelhamid, A., Ibrahim, H., Hassan, A. (2019). Assessment of the Platelet Adenosine Diphosphate Receptor (ADP Receptor p2y12) Polymorphism in Coronary Heart Diseases Patients in Ismailia. EKB Journal Management System, 22(2), 131-137. doi: 10.21608/scumj.2019.94977
Ahmed A Mohamed; Alaa Eldin S Abdelhamid; Hesham H Ibrahim; Amany M Hassan. "Assessment of the Platelet Adenosine Diphosphate Receptor (ADP Receptor p2y12) Polymorphism in Coronary Heart Diseases Patients in Ismailia". EKB Journal Management System, 22, 2, 2019, 131-137. doi: 10.21608/scumj.2019.94977
Mohamed, A., Abdelhamid, A., Ibrahim, H., Hassan, A. (2019). 'Assessment of the Platelet Adenosine Diphosphate Receptor (ADP Receptor p2y12) Polymorphism in Coronary Heart Diseases Patients in Ismailia', EKB Journal Management System, 22(2), pp. 131-137. doi: 10.21608/scumj.2019.94977
Mohamed, A., Abdelhamid, A., Ibrahim, H., Hassan, A. Assessment of the Platelet Adenosine Diphosphate Receptor (ADP Receptor p2y12) Polymorphism in Coronary Heart Diseases Patients in Ismailia. EKB Journal Management System, 2019; 22(2): 131-137. doi: 10.21608/scumj.2019.94977

Assessment of the Platelet Adenosine Diphosphate Receptor (ADP Receptor p2y12) Polymorphism in Coronary Heart Diseases Patients in Ismailia

Suez Canal University Medical Journal
Article 4, Volume 22, Issue 2, October 2019, Page 131-137  XML PDF (250.85 K)
Document Type: Original Article
DOI: 10.21608/scumj.2019.94977
View on SCiNiTO View on SCiNiTO
Authors
Ahmed A Mohamed email 1; Alaa Eldin S Abdelhamid1; Hesham H Ibrahim2; Amany M Hassan1
1Department of Clinical Pathology, Faculty of Medicine, Suez Canal University.
2Department of Cardiology, Faculty of Medicine, Suez Canal University.
Abstract
Background: Cardiovascular diseases are the leading cause of death in developed countries. In Egypt mortality rates from coronary heart disease are one of the highest worldwide, also coronary heart diseases will be the leading cause of death in developing countries by the year 2020. P2Y12 ADP receptor gene polymorphism is now considered one important implication factor in atherothrombosis and coronary heart diseases. Aim: To assess the correlation between the platelet Adenosine Diphosphate receptor (P2Y12) polymorphism and coronary heart disease patients in Ismailia. Subject and Methods: An analytical case-control study; conducted on 100 volunteers divided into 2 groups; 50 for study (patient) group and 50 for the control group at Ismailia Hospitals' Cardiology premises (clinics & inpatient department) to assess the correlation between the platelet ADP receptor (P2Y12) polymorphism and coronary heart diseases in Ismailia. The patients were subjected to an Interview Questionnaire, clinical examination, and Laboratory Investigations and testing for P2Y12 gene polymorphism. Results: In the study group, 42% of patients were hypertensive, 48% were diabetics, 60% were dyslipidemic and 66% were smokers. In the control group individuals, 26% were hypertensive, 20% were diabetics, 12% were dyslipidemic and 24% were smokers. DNA extraction and examination for P2Y12 gene polymorphism were negative in all participants. Conclusion: Our study revealed that there is no correlation between the platelet ADP receptor (P2Y12) gene polymorphism and coronary heart diseases in Ismailia.
Keywords: Ischemic heart disease, Thrombophilia, Platelet glycoproteins, Atherothrombosis
Statistics
Article View: 221
PDF Download: 241